Crosby Sheena, Schuh Michael J, Caldera Freddy, Farraye Francis A
Department of Pharmacy, Mayo Clinic, Jacksonville, Florida.
Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
Gastroenterol Hepatol (N Y). 2021 Jan;17(1):18-30.
Inflammatory bowel disease and the subsequent immunosuppressive regimens used to treat this condition increase the risk for acquiring viral and bacterial infections. Ensuring that patients are up-to-date with their immunizations may help prevent the development of several of these vaccine-preventable diseases. Therefore, it is imperative that gastroenterology providers offer vaccinations to patients or direct vaccination guidance to primary care providers to minimize the risk for vaccine-preventable diseases. To decrease the risk for co-infection in the setting of the coronavirus disease 2019 pandemic and avoid placing any further burden on the health care system, the call to immunize is more important than ever.
炎症性肠病以及用于治疗该病症的后续免疫抑制方案会增加获得病毒和细菌感染的风险。确保患者及时接种疫苗可能有助于预防几种此类可通过疫苗预防的疾病。因此，胃肠病学医疗服务提供者必须为患者提供疫苗接种服务，或为初级保健提供者提供疫苗接种指导，以将可通过疫苗预防的疾病风险降至最低。为降低2019冠状病毒病大流行背景下的合并感染风险，并避免给医疗保健系统带来任何进一步负担，进行免疫接种的呼吁比以往任何时候都更加重要。
